CRVADHPNP: Complications Related to Vascular Access Devices in Home Parenteral Nutrition Patients

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Completed
CT.gov ID
NCT05948514
Collaborator
(none)
300
1
42
7.1

Study Details

Study Description

Brief Summary

Central vascular access devices are required for home parenteral nutrition (HPN). There is few data available concerning their complications in adult HPN patients, and the potential link between venous thromboembolism and catheter infection is not well established.

The aim of this prospective cohort study is to compare the incidence rate of catheter related complications among 3 types of central vascular access: peripherally inserted central catheters; tunneled catheters and port-a-cath devices, in adults patients on HPN; describe the risk factors, and identify a potential link between venous thromboembolism and infection.

More than 300 patients will be consecutively enrolled and followed up from the time of catheter insertion until its removal. Venous complication (identify by an ultrasound examination if deep vein thrombosis is suspected), infection related to catheter and mechanical complications will be analyzed. The incidence of complications will be expressed per 1000 catheters-day and or as a percentage of total catheter.

Condition or Disease Intervention/Treatment Phase
  • Other: The complications related to central venous access device

Study Design

Study Type:
Observational
Actual Enrollment :
300 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Venous Thromboembolism and Infections Associated With Three Vascular Access Devices in Home Parenteral Nutrition : a Prospective Cohort Study
Actual Study Start Date :
Jul 1, 2017
Actual Primary Completion Date :
Jun 30, 2020
Actual Study Completion Date :
Dec 30, 2020

Arms and Interventions

Arm Intervention/Treatment
adult patients followed up in the nutrition and access device was inserted for parenteral nutrition

no intervention, observational study patients are enrolled, and followed up until a catheter related complication occurs

Other: The complications related to central venous access device
The complications related to central venous access device were collected when occurs : from time of catheter insertion, until first complication, or removal for another type of catheter, or until death.

Outcome Measures

Primary Outcome Measures

  1. Rate of (incidence) symptomatic venous thromboembolism, catheter related infection, and mechanical complications related to central venous access device [From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 36 months]

    Deep vein thrombosis of the upper extremity : suspected if symptomatic (swelling, local pain, edema) and confirmed by venous ultrasound and/or computed tomography Catheter related bloodstream infection suspected if local inflammation and/or fever, and confirmed by blood sample and/or catheter culture Mechanical complications (displacement, drop, kink) : described by nurses or patient

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients

  • having a catheter insertion during the study periode

  • at the unit of vascular access of Lyon Sud Hospital

  • for parenteral nutrition

  • from July 1st, 2017 to June 30, 2020

Exclusion Criteria:
  • catheter inserted in intensive care unit

  • for other treatment (chemotherapy, antibiotic)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Lyon Sud-Hospices Civils de Lyon Pierre BĂ©nite France 69495

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT05948514
Other Study ID Numbers:
  • 69HCL22_1128
First Posted:
Jul 17, 2023
Last Update Posted:
Jul 17, 2023
Last Verified:
Jul 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 17, 2023